Search Results - "Liprandi, María Inés Sosa"

Rationale and Design of a Multi-National Study of Physicians' Opinions, Attitudes, and Practices Regarding Influenza Vaccination in Patients with Cardiovascular Diseases: A Mixed Methods Designs. The FLUence Project by Garcia-Zamora, Sebastián, Koh, Angela S, Stoica, Svetlana, Sepehrvand, Nariman, Ranjani, Harish, Ishaku, Salisu, Herz, Naomi, Kandoole-Kabwere, Vanessa, Perel, Pablo, Banerjee, Amitava, Warren-Gash, Charlotte, Taylor, Sean, Piñeiro, Daniel José, Sosa-Liprandi, María Inés, Sosa-Liprandi, Álvaro

“…Infections, particularly those involving the respiratory tract, are associated with an increased incidence of cardiovascular events, both de novo and as…”
Get full text

Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation by Liprandi, Álvaro Sosa, Liprandi, María Inés Sosa, Zaidel, Ezequiel José, Aisenberg, Gabriel M, Baranchuk, Adrián, Barbosa, Eduardo Costa Duarte, Sánchez, Gabriela Borrayo, Alexander, Bryce, Zanetti, Fernando Tomás Lanas, Santi, Ricardo López, Múnera-Echeverri, Ana Girleza, Perel, Pablo, Piskorz, Daniel, Ruiz-Mori, Carlos Enrique, Saucedo, Jorge, Valdez, Osiris, Juanatey, José Ramón González, Piñeiro, Daniel José, Pinto, Fausto J, Quintana, Fernando Stuardo Wyss

“…Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to…”
Get full text

Endomyocardiofibrosis in the Americas Collaborative Study: The EMF-SIAC Registry by Scatularo, Cristhian E, Posada Martínez, Edith Liliana, Alba, Ana C, Renedo, María F, N Llober, Mariano, Elfman, Melisa, Pérez de Arenaza, Diego, Diez, Mirta, Saldarriaga, Clara, Cingolani, Eugenio, Sosa Liprandi, María Ines

“…Endomyocardiofibrosis (EMF) is a restrictive cardiomyopathy characterized by subendocardial fibrosis due to eosinophilic myocardial infiltration. EMF may…”
Get full text

Rationale and Design of a Multi-National Study of Physicians’ Opinions, Attitudes, and Practices Regarding Influenza Vaccination in Patients with Cardiovascular Diseases: A Mixed Methods Designs. The FLUence Project by Garcia-Zamora, Sebastián, Koh, Angela S., Stoica, Svetlana, Sepehrvand, Nariman, Ranjani, Harish, Ishaku, Salisu, Herz, Naomi, Kandoole-Kabwere, Vanessa, Perel, Pablo, Banerjee, Amitava, Warren-Gash, Charlotte, Taylor, Sean, Piñeiro, Daniel José, Sosa-Liprandi, María Inés, Sosa-Liprandi, Álvaro

“…Infections, particularly those involving the respiratory tract, are associated with an increased incidence of cardiovascular events, both de novo and as…”
Get full text

El desafío de optimizar la estratificación del riesgo cardiovascular en la mujer by Sosa Liprandi, María Inés

Get full text

The Challenge of Optimizing Cardiovascular Risk Stratification in Women by Sosa Liprandi, María Inés

Get full text

Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology by Sosa-Liprandi, Álvaro, Sosa Liprandi, María Inés, Alexánderson, Erick, Avezum, Álvaro, Lanas, Fernando, López-Jaramillo, José Patricio, Martínez, Felipe, Ponte-Negretti N, Carlos I, Wyss, Fernando, González Juanatey, José Ramón, Perel, Pablo

“…The burden of cardiovascular diseases (CVD) is increasing, particularly in low-middle-income countries such as most of Latin America. This region presents…”
Get full text

Quit Smoking: An Attainable Goal by Sosa Liprandi, María Inés, Lewkowicz, Julio Manuel

Get full text

A recent experience on the role of influenza vaccination on cardiovascular events by Sosa-Liprandi, María Inés, Zaidel, Ezequiel José, Sosa-Liprandi, Álvaro

“…The purpose of this review is to update the recent information regarding the role of influenza vaccination (IV) as a strategy to reduce cardiovascular (CV)…”
Get full text

Impact of a Telemedicine Program After a Heart Failure Hospitalization on 12 Months Follow-Up Events by Sosa Liprandi, María Inés, Elfman, Melisa, Zaidel, Ezequiel José, Viniegra, Matías, Sosa Liprandi, Álvaro

“…The aim of this study was to describe the safety, effectiveness, and usability of a mobile-app based follow up platform after a heart failure (HF)…”
Get full text

Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America by Sosa-Liprandi, Álvaro, Sosa Liprandi, María Inés, Alexánderson, Erick, Avezum, Álvaro, Lanas, Fernando, López-Jaramillo, José Patricio, Martínez, Felipe, Ponte-Negretti N, Carlos I., Wyss, Fernando, González Juanatey, José Ramón, Perel, Pablo

“…The burden of cardiovascular diseases (CVD) is increasing, particularly in low-middle-income countries such as most of Latin America. This region presents…”
Get full text

Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the World Heart Federation by Álvaro Sosa Liprandi, María Inés Sosa Liprandi, Ezequiel José Zaidel, Gabriel M. Aisenberg, Adrián Baranchuk, Eduardo Costa Duarte Barbosa, Gabriela Borrayo Sánchez, Bryce Alexander, Fernando Tomás Lanas Zanetti, Ricardo López Santi, Ana Girleza Múnera-Echeverri, Pablo Perel, Daniel Piskorz, Carlos Enrique Ruiz-Mori, Jorge Saucedo, Osiris Valdez, José Ramón González Juanatey, Daniel José Piñeiro, Fausto J. Pinto, Fernando Stuardo Wyss Quintana

“…Background: Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly…”
Get full text

Cardiac Sarcoidosis: A Clinical Overview by Alba, Ana Carolina, Gupta, Shyla, Kugathasan, Lakshmi, Ha, Andrew, Ochoa, Alejandro, Balter, Meyer, Sosa Liprandi, Alvaro, Sosa Liprandi, Maria Inés

“…Cardiac sarcoidosis (CS) with clinical manifestation occurs in about 5-8% of patients with sarcoidosis. CS may be clinically suspected by the presence of…”
Get full text

Variation in secondary prevention of coronary heart disease: the INTERASPIRE study by McEvoy, John William, Jennings, Catriona, Kotseva, Kornelia, De Bacquer, Dirk, De Backer, Guy, Erlund, Iris, Vihervaara, Terhi, Lip, Gregory Y H, Ray, Kausik K, Rydén, Lars, Abreu, Ana, Almahmeed, Wael, Ambari, Ade Meidian, Ge, Junbo, Hasan-Ali, Hosam, Huo, Yong, Jankowski, Piotr, Jimenez, Rodney M, Li, Yong, Mahmood Zuhdi, Ahmad Syadi, Makubi, Abel, Mbakwem, Amam Chinyere, Mbau, Lilian, Navarro Estrada, Jose Luis, Ogah, Okechukwu Samuel, Ogola, Elijah Nyainda, Quintero–Baiz, Adalberto, Sani, Mahmoud Umar, Sosa Liprandi, Maria Ines, Tan, Jack Wei Chieh, Urina Triana, Miguel Alberto, Yeo, Tee Joo, Ganly, Sandra, Adamska, Agnieszka, Wood, David

“…Abstract Background and Aims INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for…”
Get full text

Women Survey on Women Awareness of Heart Disease by Rolandi, Florencia, Grinfeld, Liliana, Sosa Liprandi, María Inés, Tambussi, Ana, Kazelian, Lucía, La Bruna, María Cristina, Natale, María Eugenia

Get full text

Endomyocardiofibrosis: A Systematic Review by Scatularo, Cristhian Emmanuel, Posada Martínez, Edith Liliana, Saldarriaga, Clara, Ballesteros, Oswaldo Andrés, Baranchuk, Adrian, Sosa Liprandi, Alvaro, Wyss, Fernando, Sosa Liprandi, María Ines

“…Endomyocardiofibrosis was described first time in Uganda as an infrequent restrictive cardiomyopathy with a poor prognosis, characterized by fibrosis of the…”
Get full text

Influenza and pneumococcal immunization in cardiovascular prevention by Sosa Liprandi, María Inés, Sosa Liprandi, Alvaro, Fernández, Alberto, Stecher, Daniel, Bonvehí, Pablo, Verón, María Teresa

“…A group of interdisciplinary experts (cardiologists, clinicians, infectologists met with the purpose of analyzing the evidence revealed by the relationship…”
Get full text

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial by Zannad, Faiez, Prof, Cannon, Christopher P, Prof, Cushman, William C, Prof, Bakris, George L, Prof, Menon, Venu, MD, Perez, Alfonso T, MD, Fleck, Penny R, MBA, Mehta, Cyrus R, PhD, Kupfer, Stuart, MD, Wilson, Craig, PhD, Lam, Hung, PhD, White, William B, Prof

“…Summary Background The EXAMINE trial showed non-inferiority of the DPP-4 inhibitor alogliptin to placebo on major adverse cardiac event (MACE) rates in…”
Get full text

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial by White, William B, Kupfer, Stuart, Zannad, Faiez, Mehta, Cyrus R, Wilson, Craig A, Lei, Lanyu, Bakris, George L, Nissen, Steven E, Cushman, William C, Heller, Simon R, Bergenstal, Richard M, Fleck, Penny R, Cannon, Christopher P

“…We evaluated the risk of cardiovascular (CV) death in all Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) study…”
Get full text

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin by White, William B, Wilson, Craig A, Bakris, George L, Bergenstal, Richard M, Cannon, Christopher P, Cushman, William C, Heller, Simon K, Mehta, Cyrus R, Nissen, Steven E, Zannad, Faiez, Kupfer, Stuart

“…Activation of the sympathetic nervous system when there is dipeptidyl peptidase 4 inhibition in the presence of high-dose angiotensin-converting enzyme (ACE)…”
Get full text